BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ

$52.13

-$1.18 (2.21%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$50.90$53.57

Open $53.34

52 Week Range

$50.76$73.51

Previous Close $53.31

Market Cap10.01B

Volume2.18M

Avg Volume2.69M

P/E (TTM)19.24

EPS (TTM)$2.71

Dividend / YieldN/A

Dividend StreakN/A

Latest News for BioMarin Pharmaceutical Inc.

DEC13

AQR Capital Management LLC Acquires 2,654,768 Shares of BioMarin Pharmaceutical Inc. $BMRN

AQR Capital Management LLC boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 90.7% during the undefined quarter, according to its most recent 13F filing with the SEC. The f...

defenseworld.net•3 days ago

NOV30

Critical Survey: BioMarin Pharmaceutical (NASDAQ:BMRN) & Contineum Therapeutics (NASDAQ:CTNM)

BioMarin Pharmaceutical (NASDAQ: BMRN - Get Free Report) and Contineum Therapeutics (NASDAQ: CTNM - Get Free Report) are both medical companies, but which is the superior stock? We will compare the tw...

defenseworld.net•16 days ago

NOV18

BioMarin Pharmaceutical Inc. (BMRN) Presents at Jefferies London Healthcare Conference 2025 Transcript

BioMarin Pharmaceutical Inc. ( BMRN ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants Alexander Hardy - President, CEO & Director Brian Mueller - Executi...

seekingalpha.com•27 days ago

NOV17

BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lifted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 15.4% during the second quarter, according to the company in its most recent Form 13F fi...

defenseworld.net•29 days ago

NOV17

Alberta Investment Management Corp Invests $4.02 Million in BioMarin Pharmaceutical Inc. $BMRN

Alberta Investment Management Corp acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) in the undefined quarter, according to its most recent disclosure with the Securities a...

defenseworld.net•29 days ago

NOV14

BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Acadian Asset Management LLC

Acadian Asset Management LLC grew its position in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 285.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securi...

defenseworld.net•32 days ago

NOV11

BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England

SAN RAFAEL, Calif. , Nov. 11, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the Jefferies Global Healthcare Conference on Tuesday, No...

prnewswire.com•34 days ago

OCT31

D.A. Davidson & CO. Raises Holdings in BioMarin Pharmaceutical Inc. $BMRN

D.A. Davidson and CO. grew its position in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 4.9% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commis...

defenseworld.net•46 days ago

OCT29

FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria

Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet alone FDA PDUFA target action date of...

prnewswire.com•47 days ago

OCT29

Asset Management One Co. Ltd. Has $4.84 Million Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN

Asset Management One Co. Ltd. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 8.8% during the second quarter, according to the company in its most recent 13F filing with the Secu...

defenseworld.net•48 days ago